Overactive Bladder (OAB)

Oncology·MeSH: Urinary Bladder, Overactive

6 drugs in development·3 companies·3 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
toviaz	PFIZER INC (PFE)

Phase 2(1)

Drug	Company
uro-902	Urovant Sciences Ltd. (UROV)

N/A(1)

Drug	Company
Urodynamic evaluation before and after mirabegron treatment.	Revance Therapeutics, Inc. (RVNC)

Phase 4(3)

Drug	Company
Methenamine Hippurate	Revance Therapeutics, Inc. (RVNC)
onabotulinum toxin type a	Revance Therapeutics, Inc. (RVNC)
Typically prescribed oral antibiotic prophylaxis	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 6 drugs in development for Overactive Bladder (OAB) across 3 companies.

There are 3 clinical trials targeting Overactive Bladder (OAB) tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.